Literature DB >> 29892952

Development, preclinical evaluation and validation of a novel quick vascular closure device for transluminal, cardiac and radiological arterial catheterization.

C Linti1, M Doser1, H Planck1, S Oberhoffner1, E Mueller2, M Renardy2, J Biesinger3, B Neumann3, K Stang3, T O Greiner4, C Schlensak3, S Krajewski3, H P Wendel5.   

Abstract

Following percutaneous coronary intervention, vascular closure devices (VCDs) are increasingly used to reduce time to ambulation, enhance patient comfort, and reduce potential complications compared with traditional manual compression. Newer techniques include complicated, more or less automated suture devices, local application of pads or the use of metal clips and staples. These techniques often have the disadvantage of being time consuming, expensive or not efficient enough. The VCD failure rate in association with vascular complications of 2.0-9.5%, depending on the type of VCD, is still not acceptable. Therefore, the aim of this study is to develop a self-expanding quick vascular closure device (QVCD) made from a bioabsorbable elastic polymer that can be easily applied through the placed introducer sheath. Bioabsorbable block-co-polymers were synthesized and the chemical and mechanical degradation were determined by in vitro tests. The best fitting polymer was selected for further investigation and for microinjection moulding. After comprehensive haemocompatibility analyses in vitro, QVCDs were implanted in arterial vessels following arteriotomy for different time points in sheep to investigate the healing process. The in vivo tests proved that the new QVCD can be safely placed in the arteriotomy hole through the existing sheath instantly sealing the vessel. The degradation time of 14 days found in vitro was sufficient for vessel healing. After 4 weeks, the remaining QVCD material was covered by neointima. Overall, our experiments showed the safety and feasibility of applying this novel QVCD through an existing arterial sheath and hence encourage future work with larger calibers.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29892952     DOI: 10.1007/s10856-018-6092-y

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  18 in total

1.  Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology.

Authors:  Morton J Kern; Amir Lerman; Jan-Willen Bech; Bernard De Bruyne; Eric Eeckhout; William F Fearon; Stuart T Higano; Michael J Lim; Martijn Meuwissen; Jan J Piek; Nico H J Pijls; Maria Siebes; Jos A E Spaan
Journal:  Circulation       Date:  2006-08-28       Impact factor: 29.690

Review 2.  An overview of vascular closure devices: what every radiologist should know.

Authors:  L Q Hon; A Ganeshan; S M Thomas; D Warakaulle; J Jagdish; R Uberoi
Journal:  Eur J Radiol       Date:  2008-11-28       Impact factor: 3.528

Review 3.  Vascular closure devices: a comparative overview.

Authors:  Lye-Quen Hon; Arul Ganeshan; Steven Mark Thomas; Dinuke Warakaulle; Jagalpathy Jagdish; Raman Uberoi
Journal:  Curr Probl Diagn Radiol       Date:  2009 Jan-Feb

Review 4.  Vascular Closure Devices in Interventional Radiology Practice.

Authors:  Rafiuddin Patel; Stefan Muller-Hulsbeck; Robert Morgan; Raman Uberoi
Journal:  Cardiovasc Intervent Radiol       Date:  2015-05-06       Impact factor: 2.740

5.  Histologic and duplex comparison of the perclose and angio-seal percutaneous closure devices.

Authors:  Nicholas J Gargiulo; Frank J Veith; Takao Ohki; Lawrence A Scher; George L Berdejo; Evan C Lipsitz; Mark Menegus; Mark Greenberg
Journal:  Vascular       Date:  2007 Jan-Feb       Impact factor: 1.285

Review 6.  Animal models for atherosclerosis, restenosis, and endovascular graft research.

Authors:  M Narayanaswamy; K C Wright; K Kandarpa
Journal:  J Vasc Interv Radiol       Date:  2000-01       Impact factor: 3.464

Review 7.  Vascular closure devices: the second decade.

Authors:  Harold L Dauerman; Robert J Applegate; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

8.  A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).

Authors:  S Chiu Wong; William Bachinsky; Patrick Cambier; Robert Stoler; Janah Aji; Jason H Rogers; James Hermiller; Ravi Nair; Herbert Hutman; Hong Wang
Journal:  JACC Cardiovasc Interv       Date:  2009-08       Impact factor: 11.195

9.  Predicting vascular complications in percutaneous coronary interventions.

Authors:  Winthrop D Piper; David J Malenka; Thomas J Ryan; Samuel J Shubrooks; Gerald T O'Connor; John F Robb; Karen L Farrell; Mary S Corliss; Michael J Hearne; Mirle A Kellett; Matthew W Watkins; William A Bradley; Bruce D Hettleman; Theodore M Silver; Paul D McGrath; John R O'Mears; David E Wennberg
Journal:  Am Heart J       Date:  2003-06       Impact factor: 4.749

Review 10.  [Immediate hemostasis of the femoral artery after heart catheterization: the present situation of closure systems].

Authors:  P Lochow; S Silber
Journal:  Dtsch Med Wochenschr       Date:  2004-08-13       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.